Trade Basilea Pharma AG - BSLN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.012132% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.01009% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | CHF | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Switzerland | ||||||||
| Commission on trade | 0% |
| Prev. Close | 41.6 |
| Open | 40.5 |
| 1-Year Change | 18.77% |
| Day's Range | 39.5 - 41.4 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 17, 2025 | 40.35 | -0.85 | -2.06% | 41.20 | 41.45 | 39.45 |
| Jan 16, 2025 | 41.60 | 1.15 | 2.84% | 40.45 | 41.75 | 39.75 |
| Jan 15, 2025 | 39.65 | -0.45 | -1.12% | 40.10 | 40.45 | 38.55 |
| Jan 14, 2025 | 40.85 | -0.10 | -0.24% | 40.95 | 40.95 | 39.45 |
| Jan 13, 2025 | 40.50 | -1.05 | -2.53% | 41.55 | 41.90 | 40.50 |
| Jan 10, 2025 | 41.95 | -0.40 | -0.94% | 42.35 | 42.50 | 41.20 |
| Jan 9, 2025 | 42.65 | -0.20 | -0.47% | 42.85 | 43.05 | 41.75 |
| Jan 8, 2025 | 42.15 | -0.80 | -1.86% | 42.95 | 44.00 | 42.15 |
| Jan 7, 2025 | 41.85 | 0.00 | 0.00% | 41.85 | 42.95 | 41.35 |
| Jan 6, 2025 | 42.50 | 1.15 | 2.78% | 41.35 | 42.75 | 40.35 |
| Jan 3, 2025 | 41.30 | 0.75 | 1.85% | 40.55 | 41.35 | 40.00 |
| Dec 30, 2024 | 40.50 | -0.95 | -2.29% | 41.45 | 41.80 | 40.50 |
| Dec 27, 2024 | 41.65 | 0.70 | 1.71% | 40.95 | 41.85 | 40.25 |
| Dec 23, 2024 | 40.20 | -0.95 | -2.31% | 41.15 | 41.30 | 40.20 |
| Dec 20, 2024 | 41.35 | 0.30 | 0.73% | 41.05 | 41.40 | 40.45 |
| Dec 19, 2024 | 41.20 | 0.25 | 0.61% | 40.95 | 41.45 | 40.20 |
| Dec 18, 2024 | 41.45 | -0.15 | -0.36% | 41.60 | 42.00 | 40.45 |
| Dec 17, 2024 | 41.20 | -0.45 | -1.08% | 41.65 | 41.65 | 40.20 |
| Dec 16, 2024 | 42.25 | -1.15 | -2.65% | 43.40 | 43.80 | 41.00 |
| Dec 13, 2024 | 40.05 | 0.25 | 0.63% | 39.80 | 40.35 | 39.20 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Basilea Company profile
About Basilea Pharmaceutica AG
Basilea Pharmaceutica AG is a Switzerland-based commercial-stage biopharmaceutical company. The Company operates in one segment, which is the discovery, development and commercialization of innovative pharmaceutical products to meet the needs of patients with cancer and infectious diseases. It launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. Additionally It is conducting clinical studies with two targeted drug candidates for the treatment of a range of cancers and have a number of preclinical assets in both cancer and infectious diseases in its portfolio.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Basilea Pharmaceutica AG revenues increased 16% to SF148.1M. Net loss decreased 54% to SF6.8M. Revenues reflect Japan segment increase of 41% to SF56.5M, Republic of Ireland segment increase of 9% to SF62.1M. Lower net loss reflects Research & development expenses, net - B decrease of 4% to SF91.6M (expense), Stock-based Compensation in SGA decrease of 6% to SF1.7M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
Hegenheimermattweg 167b
ALLSCHWIL
BASEL-LANDSCHAFT 4123
CH
News
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com